RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00035024.xml
PDF herunterladen
Thromb Haemost 2008; 100(05): 727-728
DOI: 10.1160/TH-08-09-0576
DOI: 10.1160/TH-08-09-0576
Editorial Focus
Thyroid disease and haemostasis – a relationship with clinical implications?
Weitere Informationen
Publikationsverlauf
Received
04. September 2008
Accepted
04. September 2008
Publikationsdatum:
22. November 2017 (online)
-
References
- 1 Squizzato A, Romualdi E, Buller HR. et al. Thyroid dysfunction and effects on coagulation and fibrinolysis: a systematic review. J Clin Endocrinol Metab 2007; 92: 2415-2420.
- 2 Manfredi E, van Zaane B, Gerdes VEA. et al. Hypothyroidism and acquired von Willebrand’s syndrome: a systematic review. Haemophilia 2008; 14: 423-433.
- 3 Kurnik D, Loebstein R, Farfel Z. et al. Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland. Medicine (Baltimore) 2004; 83: 107-113.
- 4 Van Oosterom AT, Mattie H, Hermens WT. et al. The influence of the thyroid function on the metabolic rate of prothrombin, factor VII, and factor X in the rat. Thromb Haemost 1976; 35: 607-619.
- 5 Bucerius J, Naubereit A, Joe AY. et al. Subclinical hyperthyroidism seems not to have a significant impact on systemic anticoagulation in patients with coumarin therapy. Thromb Haemost 2008; 100: 803-809.
- 6 Azar AJ, Dekkers JW, Rosendaal FR. et al. Assessment of therapeutic quality control in a long-term anticoagulant trial in post-myocardial infaction patients. Thromb Haemost 1994; 72: 347-351.